CDMO Historical PE Ratio image   This CDMO PE ratio history page last updated 12/8/2022
CDMO Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2023
12/6/2022
14.88-0.03-0.12NA
Q1 2023
9/6/2022
15.960.050.2079.8
Q4 2022
6/29/2022
15.170.010.04379.2
Q3 2022
3/8/2022
17.530.040.16109.6
Q2 2022
12/7/2021
28.500.060.24118.8
Q1 2022
9/8/2021
23.650.100.4059.1
Q4 2021
6/29/2021
24.07-0.04-0.16NA
Q3 2021
3/8/2021
17.530.010.04438.2
Q2 2021
12/2/2020
9.500.010.04237.5
Q1 2021
9/1/2020
8.520.060.2435.5
Q4 2020
6/30/2020
6.57-0.11-0.44NA
Q3 2020
3/10/2020
5.99-0.06-0.24NA
Q2 2020
12/9/2019
5.85-0.03-0.12NA
Q1 2020
9/5/2019
7.05-0.08-0.32NA
Q4 2019
6/27/2019
4.00-0.02-0.08NA
Q3 2019
3/11/2019
4.12-0.05-0.20NA
Q2 2019
12/10/2018
5.20-0.06-0.24NA
Q1 2019
9/10/2018
7.17-0.06-0.24NA
Q4 2018
7/16/2018
4.47-0.14-0.56NA
Q3 2018
3/12/2018
2.44-0.23-0.92NA
Q2 2018
12/11/2017
5.35-0.28-1.12NA
Q1 2018
9/11/2017
3.23-0.06-0.24NA
Q4 2017
7/14/2017
5.58-0.16-0.64NA
Q3 2017
3/13/2017
0.76-0.28-1.12NA
Q2 2017
12/12/2016
0.37-0.14-0.56NA
Q1 2017
9/8/2016
0.42-0.35-1.40NA
Q4 2016
7/14/2016
0.43-0.35-1.40NA
Q3 2016
3/9/2016
0.43-0.56-2.24NA
Q2 2016
12/10/2015
1.22-0.49-1.96NA
Q1 2016
9/9/2015
1.21-0.56-2.24NA
Q4 2015
7/14/2015
1.35-0.49-1.96NA
Q3 2015
3/12/2015
1.45-0.56-2.24NA
Q2 2015
12/10/2014
1.49-0.49-1.96NA
Q1 2015
9/9/2014
1.55-0.56-2.24NA
Q4 2014
7/14/2014
1.76-0.42-1.68NA
Q3 2014
3/7/2014
2.40-0.42-1.68NA
Q2 2014
12/10/2013
1.270.351.400.9
Q1 2014
9/9/2013
1.52-0.35-1.40NA
Q4 2013
7/11/2013
1.53-0.42-1.68NA
Q3 2013
3/12/2013
1.58-0.28-1.12NA
Q2 2013
12/10/2012
1.23-0.56-2.24NA
Q1 2013
9/10/2012
4.34-0.49-1.96NA
Q4 2012
7/16/2012
1.06-0.70-2.80NA
CDMO PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2023
12/6/2022
14.88-0.030.07212.6
Q1 2023
9/6/2022
15.960.050.1699.8
Q4 2022
6/29/2022
15.170.010.2172.2
Q3 2022
3/8/2022
17.530.040.16109.6
Q2 2022
12/7/2021
28.500.060.13219.2
Q1 2022
9/8/2021
23.650.100.08295.6
Q4 2021
6/29/2021
24.07-0.040.04>500
Q3 2021
3/8/2021
17.530.01-0.03NA
Q2 2021
12/2/2020
9.500.01-0.10NA
Q1 2021
9/1/2020
8.520.06-0.14NA
Q4 2020
6/30/2020
6.57-0.11-0.28NA
Q3 2020
3/10/2020
5.99-0.06-0.19NA
Q2 2020
12/9/2019
5.85-0.03-0.18NA
Q1 2020
9/5/2019
7.05-0.08-0.21NA
Q4 2019
6/27/2019
4.00-0.02-0.19NA
Q3 2019
3/11/2019
4.12-0.05-0.31NA
Q2 2019
12/10/2018
5.20-0.06-0.49NA
Q1 2019
9/10/2018
7.17-0.06-0.71NA
Q4 2018
7/16/2018
4.47-0.14-0.71NA
Q3 2018
3/12/2018
2.44-0.23-0.73NA
Q2 2018
12/11/2017
5.35-0.28-0.78NA
Q1 2018
9/11/2017
3.23-0.06-0.64NA
Q4 2017
7/14/2017
5.58-0.16-0.93NA
Q3 2017
3/13/2017
0.76-0.28-1.12NA
Q2 2017
12/12/2016
0.37-0.14-1.40NA
Q1 2017
9/8/2016
0.42-0.35-1.75NA
Q4 2016
7/14/2016
0.43-0.35-1.96NA
Q3 2016
3/9/2016
0.43-0.56-2.10NA
Q2 2016
12/10/2015
1.22-0.49-2.10NA
Q1 2016
9/9/2015
1.21-0.56-2.10NA
Q4 2015
7/14/2015
1.35-0.49-2.10NA
Q3 2015
3/12/2015
1.45-0.56-2.03NA
Q2 2015
12/10/2014
1.49-0.49-1.89NA
Q1 2015
9/9/2014
1.55-0.56-1.05NA
Q4 2014
7/14/2014
1.76-0.42-0.84NA
Q3 2014
3/7/2014
2.40-0.42-0.84NA
Q2 2014
12/10/2013
1.270.35-0.70NA
Q1 2014
9/9/2013
1.52-0.35-1.61NA
Q4 2013
7/11/2013
1.53-0.42-1.75NA
Q3 2013
3/12/2013
1.58-0.28-2.03NA
Q2 2013
12/10/2012
1.23-0.56NANA
Q1 2013
9/10/2012
4.34-0.49NANA
Q4 2012
7/16/2012
1.06-0.70NANA
Quotes delayed 20 minutes

Email EnvelopeFree CDMO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Avid Bioservices (CDMO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CDNA PE Ratio History
CDRE PE Ratio History
CDTX PE Ratio History
CDXC PE Ratio History
CELC PE Ratio History
CEMI PE Ratio History
CERC PE Ratio History
CERE PE Ratio History
CERS PE Ratio History
CFMS PE Ratio History
How should the CDMO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Avid Bioservices. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CDMO Historical PE Ratio page.

What is the average historical PE for CDMO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CDMO historical PE ratio using the annualized quarterly earnings method works out to 162.1.

What is the average historical PE for CDMO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CDMO historical PE ratio using the TTM earnings method works out to 168.2.

What is the average historical PE for CDMO based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The CDMO historical PE ratio using the annualized median TTM earnings method works out to 0.12.

On this page we presented the CDMO Historical PE Ratio information for Avid Bioservices' stock. The average CDMO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 162.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CDMO historical PE based on this TTM earnings result method is 168.2. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CDMO historical PE result, against the recent PE: when this page was posted on 12/7/2022, the most recent closing price for CDMO had been 13.04, and the most recent quarterly earnings result, annualized, was 0.2. Meanwhile, the most recent TTM earnings summed to 0.07. From these numbers, we calculate the recent CDMO PE on 12/7/2022 based on annualized quarterly EPS was 65.2. Based on CDMO's history, that recent PE is low relative to the historical average, with the recent PE 59.8% lower than the historical average PE across our data set for Avid Bioservices. Looking at the recent CDMO PE on 12/7/2022 based on TTM EPS, we calculate the ratio at 186.3. Based on CDMO's history, that recent PE is elevated relative to the historical average, with the recent PE 10.8% higher than the historical average PE across our Avid Bioservices data set with TTM EPS used in the calculation at each period.

Another interesting CDMO historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for CDMO, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for CDMO, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.03, 0.01, 0.04, and 0.05. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.01 and 0.04 — which gives us the median of 0.03. Basically the way to think about this 0.03 number is this: for the trailing four earnings reports, 0.03 marks the "middle ground" number where CDMO has reported a value higher than 0.03 half the time, and has reported a value lower than 0.03 half the time. Annualizing that median value then gets us to 0.12/share, which we use as the denominator in our next PE calculation. With 13.04 as the numerator (as of 12/7/2022), the calculation is then 13.04 / 0.12 = 108.7 as the CDMO PE ratio as of 12/7/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on CDMO or any other given stock, valuation analysis for CDMO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Avid Bioservices PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CDMO. Thanks for visiting, and the next time you need to research CDMO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Heico Next Earnings Date, CCNE YTD Return, Institutional Holders of IMED.

 

CDMO Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.